HuGE Literature Finder
Records
1
-
9
| Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma. Journal of oncology 2022 2022 9854788. Wen Chen-Yueh, Tsui Kuan-Hao, Chang Chiung-Hung, Chiu Yi-Han, Lin Shu-Chuan Amy, Chu Ching-Yu, Li Chia-Ju |
| Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort. International journal of cancer 2020 Nov . Aparicio Thomas, Svrcek Magali, Henriques Julie, Afchain Pauline, Lièvre Astrid, Tougeron David, Gagniere Johan, Terrebonne Eric, Piessen Guillaume, Legoux Jean-Louis, Lecaille Cédric, Pocard Marc, Gornet Jean-Marc, Zaanan Aziz, Lavau-Denes Sandrine, Lecomte Thierry, Deutsch David, Vernerey Dewi, Laurent Puig Pier |
| Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomas. Bosnian journal of basic medical sciences 2019 Aug . Argadal Omer Gokay, Mutlu Melis, Ak Aksoy Secil, Kocaeli Hasan, Tunca Berrin, Civan Muhammet Nafi, Egeli Unal, Cecener Gulsah, Bekar Ahmet, Taskapilioglu Mevlut Ozgur, Tekin Cagla, Tezcan Gulcin, Tolunay Sahsi |
| Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations. Human pathology 2018 Aug 78 138-143. Toth Laura N, de Abreu Francine B, Tafe Laura |
| Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation. Inflammatory bowel diseases 2018 May . Hartman Douglas J, Binion David G, Regueiro Miguel D, Miller Caitlyn, Herbst Cameron, Pai Reetesh |
| Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
| Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Cancer biomarkers : section A of Disease markers 2017 Oct . Masetti Michele, Acquaviva Giorgia, Visani Michela, Tallini Giovanni, Fornelli Adele, Ragazzi Moira, Vasuri Francesco, Grifoni Daniela, Giacomo Simone Di, Fiorino Sirio, Lombardi Raffaele, Tuminati David, Ravaioli Matteo, Fabbri Carlo, Bacchi-Reggiani Maria Letizia, Pession Annalisa, Jovine Elio, de Biase Dar |
| Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. Oncotarget 2015 Aug 6 (25): 20863-74. Alvi Muhammad A, McArt Darragh G, Kelly Paul, Fuchs Marc-Aurel, Alderdice Matthew, McCabe Clare M, Bingham Victoria, McGready Claire, Tripathi Shailesh, Emmert-Streib Frank, Loughrey Maurice B, McQuaid Stephen, Maxwell Perry, Hamilton Peter W, Turkington Richard, James Jacqueline A, Wilson Richard H, Salto-Tellez Manu |
| Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clinical chemistry 2014 Jul 60 (7): 1004-11. Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: